Dentons is the world’s largest law firm and recognized by prominent business and legal publications for its innovations in client service. But, they are also pioneering the intersection of technology innovation and the legal industry and also exploring legislation and regulation around emerging technologies. I have already spoken to guests from Dentons about smart cities and autonomous cars. But today I want to explore the effects tech, and legal tech is having on the emerging Cannabis industry, Ausra Deluard is a member of Dentons’ national Health Care practice group, resident in the Oakland office. Her current practice focus is on helping clients in the nascent cannabis industry achieve their business objectives by advising them on the sector’s rapidly evolving laws and regulations. Ausra’s experience in high-stakes antitrust litigation in the M&A context and in civil and criminal investigations was excellent preparation for counseling companies in avoiding the liability risks of operating in a highly regulated consumer industry. Ausra meanwhile continues to advise clients in a range of sectors on contentious and non-contentious antitrust matters relating to proposed acquisitions, gun-jumping, global pricing and distribution policies, competitor collaboration, licensing arrangements, interlocking directorates, and pharmaceutical settlements. She has handled numerous “second request” merger investigations before the Department of Justice and Federal Trade Commission for clients in the cannabis, tobacco, health care and technology sectors, using cutting-edge technology to efficiently and cost-effectively manage HSR Act investigations and persuasive advocacy to resolve substantive competition law issues.